Brain cell atlas reveals common mechanisms in neurodegenerative diseases

Researchers have developed a large-scale molecular atlas of the dorsolateral prefrontal cortex, marking a significant advancement in understanding brain diseases. Supported by the National Institutes of Health (NIH), an international consortium analyzed over 6.3 million nuclei from brain tissue belonging to nearly 1,500 individuals.

The study, published in the journal Nature as part of the PsychAD project, identifies common mechanisms across various brain diseases while highlighting specific changes unique to individual conditions. In Alzheimer's disease, the data reveals how populations of neurons, immune cells, and blood vessel-associated cells change as the disease progresses.

This detailed cellular mapping is expected to assist researchers in identifying more precise biomarkers and therapeutic targets for neurodegenerative and neuropsychiatric disorders. By studying gene activity at the individual cell level, scientists can better understand how biological processes differ between various stages of a disease and across different cell types.